Condition
Coronary Circulation
Total Trials
6
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 3 (1)
Trial Status
Unknown3
Completed3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT03193294Not ApplicableCompleted
CORonary MICrovascular Angina (CorMicA)
NCT04575207Not ApplicableUnknown
The Flash FFR Ⅱ Study
NCT03656848Not ApplicableUnknown
The FAVOR III China Study
NCT03067844Phase 3Completed
Vascular Effects of Alirocumab in Acute MI-Patients
NCT03033810Unknown
FFR Versus iFR in Assessment of Hemodynamic Lesion Significance
NCT00925834Not ApplicableCompletedPrimary
Suggestive Effects on the Diameter of Coronary Arteries
Showing all 6 trials